查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1985847

美國醫療被動式低溫運輸包裝市場規模、佔有率和趨勢分析報告：按產品、溫度要求、最終用途和細分市場分類，預測期為2026-2033年

U.S. Healthcare Passive Cold Chain Packaging Market Size, Share & Trends Analysis Report By Product, By Temperature Requirement (Cool / Controlled Chilled, Controlled Room Temperature ), By End Use, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

美國醫療被動式低溫運輸包裝市場概述

2025 年美國醫療被動低溫運輸包裝市場價值為 22.2 億美元，預計到 2033 年將達到 54.5 億美元，2026 年至 2033 年的複合年成長率為 11.9%。

該行業的主要驅動力是溫度敏感型生技藥品、疫苗和先進治療方法的生產和分銷不斷增加，這些都需要可靠且檢驗的被動式溫度控制解決方案。

此外，由於被動式系統具有成本效益高、操作簡便的優點，因此在國內醫療物流領域得到了廣泛應用，尤其是在最後一公里配送和直接送達患者方面。

對溫度敏感型生物製藥和疫苗日益成長的需求是美國醫療被動式低溫運輸包裝行業最重要的成長要素之一。與傳統藥品不同，單株抗體、細胞和基因療法以及重組蛋白等生物製藥對溫度波動極為敏感。即使輕微超出建議溫度範圍，也會損害產品療效，因此，可靠的被動式低溫運輸解決方案對於在儲存和運輸過程中保護藥品品質至關重要。

美國憑藉著強大的藥物創新能力和不斷成長的先進治療方法核准，繼續引領全球生物製藥的研發和商業化進程。這些產品需要透過醫院、專科藥局、臨床試驗中心以及日益增加的直接配送管道分發給病患。被動式低溫運輸包裝，例如保溫運輸容器、相變材料和冰袋，提供了一種擴充性且經濟高效的方法，無需像使用全套主動式製冷系統那樣增加運作負擔，即可確保溫度控制。

隨著免疫接種計劃的擴大、季節性流感疫苗供應鏈的完善以及應對突發公共衛生事件準備工作的加強，疫苗需求持續成長。疫苗分發涉及巨大的運輸量、不穩定的運輸時間和複雜的「最後一公里」配送要求。被動式包裝因其柔軟性、低成本以及在各種氣候和運輸條件下久經考驗的性能而備受青睞。

此外，電子商務在醫療物流領域的廣泛應用正成為推動產業發展的主要動力。醫療產品分銷管道正從醫院和批發商等傳統管道擴展到包括數位化訂購平台、專科藥房網路和直接送達患者等模式。例如，為類風濕性關節炎和多發性硬化症患者提供生物製藥的專科藥房，擴大依賴保溫小包裹容器，以確保產品在送貨上門過程中保持在規定的2-8°C範圍內。這種結構性轉變正顯著推動市場對檢驗的被動式低溫運輸包裝解決方案的需求成長。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：美國醫療被動式低溫運輸包裝市場的因素、趨勢與範圍

  • 市場展望
  • 滲透率和成長預測圖
  • 產業價值鏈分析
    • 原料趨勢
    • 製造業趨勢
  • 永續性和可重複利用性的發展趨勢
  • 法律規範
  • 市場動態
  • 商業環境分析
    • 波特五力分析
    • PESTEL 分析

第4章：美國醫療被動式低溫運輸包裝市場：依產品類別分類的估價與趨勢分析

  • 產品特定波動分析及市場佔有率（2025 年和 2033 年）
    • 保溫容器
    • 保溫托盤運輸車
    • 凝膠包、乾冰系統、相變材料
    • 其他

第5章：美國醫療被動式低溫運輸包裝市場：依溫度要求分類的估算與趨勢分析

  • 按溫度需求分類的波動和市場佔有率分析（2025 年和 2033 年）
    • 冷藏/冷凍（2 度C至 8 度C）
    • 冷凍（-20度C 至 ±5度C）
    • 冷藏/控溫冷藏（8°C 至 15°C）
    • 受控室溫（CRT）
    • 超低溫冷凍（-40 度C至 -60 度C）

第6章：美國醫療被動式低溫運輸包裝市場：依最終用途分類的估算與趨勢分析

  • 按最終用途分類的波動和市場佔有率分析（2025 年和 2033 年）
    • 製藥和生物製藥公司
    • 醫院和醫療機構
    • 診斷和病理檢測實驗室
    • 研究機構和學術研究機構
    • 臨床研究組織（CRO）
    • 血庫/血漿採集中心
    • 其他

第7章 競爭情勢

  • 主要企業、近期趨勢及其對產業的影響
  • 供應商情況
    • 公司分類
    • 原料供應商和通路夥伴名單
    • 潛在客戶名單
  • 競爭環境
    • 企業市場分析
    • 公司熱圖分析
    • 策略藍圖

第8章：公司列表（概述、財務表現、產品概述）

  • Company Overview
  • 財務業績
  • 產品基準測試
  • Cold Chain Technologies
  • Peli BioThermal LLC
  • Cryopak
  • CSafe
  • Intelsius
  • TemperPack
  • Coldkeepers, LLC
  • Polar Tech Industries
  • Creative Packaging Co.
  • ThermoSafe
Product Code: GVR-4-68040-848-5

U.S. Healthcare Passive Cold Chain Packaging Market Summary

The U.S. healthcare passive cold chain packaging market size was valued at USD 2.22 billion in 2025 and is projected to reach USD 5.45 billion by 2033, expanding at a CAGR of 11.9% from 2026 to 2033. The industry is primarily driven by the rising production and distribution of temperature-sensitive biologics, vaccines, and advanced therapies, which demand reliable, validated passive temperature control solutions.

Additionally, cost-efficiency and operational simplicity of passive systems make them widely adopted across domestic healthcare logistics, especially for last-mile and direct-to-patient shipments.

The rising demand for temperature-sensitive biologics and vaccines is one of the most significant growth drivers for the U.S. healthcare passive cold chain packaging industry. Unlike conventional pharmaceuticals, biologics such as monoclonal antibodies, cell and gene therapies, and recombinant proteins are highly vulnerable to temperature variations. Even limited exposure outside recommended ranges can compromise product efficacy, making reliable passive cold chain solutions essential for protecting drug quality during storage and distribution.

The U.S. remains a global leader in biologics development and commercialization, supported by strong pharmaceutical innovation and increasing approvals of advanced therapies. These products require distribution across hospitals, specialty pharmacies, clinical trial sites, and increasingly direct-to-patient channels. Passive cold chain packaging, including insulated shippers, phase change materials, and gel packs, offers a scalable and cost-effective approach to ensure temperature control without the operational burden of fully active refrigeration systems.

Vaccines further strengthen this demand, particularly with the expansion of immunization programs, seasonal influenza supply chains, and broader preparedness for public health emergencies. Vaccine distribution involves high shipment volumes, variable transit durations, and complex last-mile delivery requirements. Passive packaging is widely preferred due to its flexibility, lower cost structure, and validated performance across diverse climate and transportation conditions.

Moreover, the increasing adoption of e-commerce in healthcare logistics is becoming a major growth driver for the industry. Healthcare distribution is expanding beyond traditional hospital and wholesaler channels toward digital ordering platforms, specialty pharmacy networks, and direct-to-patient delivery models. For example, specialty pharmacies shipping biologics for rheumatoid arthritis or multiple sclerosis now rely heavily on insulated parcel shippers to ensure products remain within the required 2-8°C range during doorstep delivery. This structural shift is significantly increasing demand for validated passive cold chain packaging solutions.

U.S. Healthcare Passive Cold Chain Packaging Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. healthcare passive cold chain packaging market report based on product, temperature requirement, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
    • Insulated Containers
    • Insulated Pallet Shippers
    • Gel Packs, Dry Ice Systems, PCM
    • Others
  • Temperature Requirement Outlook (Revenue, USD Million, 2021 - 2033)
    • Refrigerated / Chilled (2°C to 8°C)
    • Frozen (-20 °C to +-5 °C)
    • Cool / Controlled Chilled (8 °C to 15 °C)
    • Controlled Room Temperature (CRT)
    • Deep Frozen (-40 °C to -60 °C)
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
    • Pharmaceutical & Biopharmaceutical Companies
    • Hospitals & Healthcare Providers
    • Diagnostic & Pathology Laboratories
    • Research Institutes & Academic Laboratories
    • Clinical Research Organizations (CROs)
    • Blood Banks & Plasma Collection Centers
    • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Research Methodology
    • 1.1.1. Market Segmentation
    • 1.1.2. Market Definition
  • 1.2. Research Scope & Assumptions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot (USD Million)
  • 2.2. Segmental Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Healthcare Passive Cold Chain Packaging Market Variables, Trends, and Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Raw Material Trends
    • 3.3.2. Manufacturing Trends
  • 3.4. Sustainability and Reusability Trends
  • 3.5. Regulatory Framework
  • 3.6. Market Dynamics
    • 3.6.1. Market Driver Analysis
    • 3.6.2. Market Restraint Analysis
    • 3.6.3. Market Opportunity Analysis
    • 3.6.4. Market Challenge Analysis
  • 3.7. Business Environment Analysis
    • 3.7.1. Porter's Five Forces Analysis
    • 3.7.2. PESTEL Analysis

Chapter 4. U.S. Healthcare Passive Cold Chain Packaging Market: Product Estimates & Trend Analysis

  • 4.1. Key Takeaways
  • 4.2. Products Movement Analysis & Market Share, 2025 & 2033
    • 4.2.1. Insulated Containers
      • 4.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.2.2. Insulated Pallet Shippers
      • 4.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.2.3. Gel Packs, Dry Ice Systems, PCM
      • 4.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.2.4. Others
      • 4.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Healthcare Passive Cold Chain Packaging Market: Temperature Requirement Estimates & Trend Analysis

  • 5.1. Key Takeaways
  • 5.2. Temperature Requirement Movement Analysis & Market Share, 2025 & 2033
    • 5.2.1. Refrigerated / Chilled (2°C to 8°C)
      • 5.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.2.2. Frozen (-20 °C to +-5 °C)
      • 5.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.2.3. Cool / Controlled Chilled (8 °C to 15 °C)
      • 5.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.2.4. Controlled Room Temperature (CRT)
      • 5.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.2.5. Deep Frozen (-40 °C to -60 °C)
      • 5.2.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Healthcare Passive Cold Chain Packaging Market: End Use Estimates & Trend Analysis

  • 6.1. Key Takeaways
  • 6.2. End Use Movement Analysis & Market Share, 2025 & 2033
    • 6.2.1. Pharmaceutical & Biopharmaceutical Companies
      • 6.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.2.2. Hospitals & Healthcare Providers
      • 6.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.2.3. Diagnostic & Pathology Laboratories
      • 6.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.2.4. Research Institutes & Academic Laboratories
      • 6.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.2.5. Clinical Research Organizations (CROs)
      • 6.2.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.2.6. Blood Banks & Plasma Collection Centers
      • 6.2.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.2.7. Others
      • 6.2.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Key Players & Recent Developments & Their Impact on the Industry
  • 7.2. Vendor Landscape
    • 7.2.1. Company Categorization
    • 7.2.2. List of Raw Material Suppliers and Channel Partners
    • 7.2.3. List of Potential Customers
  • 7.3. Competitive Dynamics
    • 7.3.1. Company Market Position Analysis
    • 7.3.2. Company Heat Map Analysis
    • 7.3.3. Strategy Mapping
      • 7.3.3.1. Expansions
      • 7.3.3.2. Mergers & Acquisitions
      • 7.3.3.3. Collaborations
      • 7.3.3.4. New Product Launches
      • 7.3.3.5. Others

Chapter 8. Company Listing (Overview, Financial Performance, Product Overview)

  • 8.1. Company Overview
  • 8.2. Financial Performance
  • 8.3. Product Benchmarking
  • 8.4. Cold Chain Technologies
  • 8.5. Peli BioThermal LLC
  • 8.6. Cryopak
  • 8.7. CSafe
  • 8.8. Intelsius
  • 8.9. TemperPack
  • 8.10. Coldkeepers, LLC
  • 8.11. Polar Tech Industries
  • 8.12. Creative Packaging Co.
  • 8.13. ThermoSafe

List of Tables

  • Table 1 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 2 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Insulated Containers, 2021 - 2033 (USD Million)
  • Table 3 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Insulated Pallet Shippers , 2021 - 2033 (USD Million)
  • Table 4 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Gel Packs, Dry Ice Systems, PCM, 2021 - 2033 (USD Million)
  • Table 5 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Others, 2021 - 2033 (USD Million)
  • Table 6 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Temperature Requirement, 2021 - 2033 (USD Million)
  • Table 7 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Refrigerated / Chilled (2°C to 8°C), 2021 - 2033 (USD Million)
  • Table 8 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Frozen (-20 °C to +-5 °C), 2021 - 2033 (USD Million)
  • Table 9 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Cool / Controlled Chilled (8 °C to 15 °C), 2021 - 2033 (USD Million)
  • Table 10 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Controlled Room Temperature (CRT), 2021 - 2033 (USD Million)
  • Table 11 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by Deep Frozen (-40 °C to -60 °C), 2021 - 2033 (USD Million)
  • Table 12 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, in Pharmaceutical & Biopharmaceutical Companies, 2021 - 2033 (USD Million)
  • Table 14 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, in Hospitals & Healthcare Providers, 2021 - 2033 (USD Million)
  • Table 15 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, in Diagnostic & Pathology Laboratories, 2021 - 2033 (USD Million)
  • Table 16 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, in Research Institutes & Academic Laboratories, 2021 - 2033 (USD Million)
  • Table 17 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, in Clinical Research Organizations (CROs), 2021 - 2033 (USD Million)
  • Table 18 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, in Blood Banks & Plasma Collection Centers, 2021 - 2033 (USD Million)
  • Table 19 U.S. Healthcare Passive Cold Chain Packaging market estimates and forecasts, in Others, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Primary Research Process
  • Fig. 4 Market Research Approaches - Bottom-Up Approach
  • Fig. 5 Market Research Approaches - Top-Down Approach
  • Fig. 6 Market Research Approaches - Combined Approach
  • Fig. 7 U.S. Healthcare Passive Cold Chain Packaging Market- Market Snapshot
  • Fig. 8 U.S. Healthcare Passive Cold Chain Packaging Market- Segment Snapshot
  • Fig. 9 U.S. Healthcare Passive Cold Chain Packaging Market- Competitive Landscape Snapshot
  • Fig. 10 U.S. Healthcare Passive Cold Chain Packaging Market: Value Chain Analysis
  • Fig. 11 U.S. Healthcare Passive Cold Chain Packaging Market: Porter's Five Force Analysis
  • Fig. 12 U.S. Healthcare Passive Cold Chain Packaging Market: PESTEL Analysis
  • Fig. 13 U.S. Healthcare Passive Cold Chain Packaging Market: Product Movement Analysis, 2025 & 2033
  • Fig. 14 U.S. Healthcare Passive Cold Chain Packaging Market: Temperature Requirement Movement Analysis, 2025 & 2033
  • Fig. 15 U.S. Healthcare Passive Cold Chain Packaging Market: End Use Movement Analysis, 2025 & 2033
  • Fig. 16 U.S. Healthcare Passive Cold Chain Packaging Market: Company Positioning Analysis
  • Fig. 17 U.S. Healthcare Passive Cold Chain Packaging Market: Strategy Mapping